| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/16/2009 | EP2132013A1 Thin metal nanowires produced by biotemplating |
| 12/16/2009 | EP2131857A2 Method of preparing an immunologically-active adjuvant-bound dried vaccine composition |
| 12/16/2009 | EP1773870B1 Methods for the production of peptide having a c-terminal amide |
| 12/16/2009 | EP1636593B9 Modulating the interaction between hgf beta chain and c-met |
| 12/16/2009 | EP1604020B1 Method to confer cell culture replication activity to different hepatitis c virus isolates |
| 12/16/2009 | EP1597381B1 Production of modified glycoproteins having multiple antennary structures |
| 12/16/2009 | EP1576159B9 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering |
| 12/16/2009 | EP1521832B1 Anti-fragilis antibody and uses thereof |
| 12/16/2009 | EP1407023B1 Group b streptococcus antigens and corresponding dna fragments |
| 12/16/2009 | EP1287147B1 Immunotoxin fusion proteins and means for expression thereof |
| 12/16/2009 | EP1135469B1 An improved method for the production and purification of adenoviral vectors |
| 12/16/2009 | EP1114189B1 Recombinant newcastle disease virus rna expression systems and vaccines |
| 12/16/2009 | EP0996455B1 Alpha-o-linked glycoconjugates with clustered (2,6)-st epitopes, methods of preparation and uses thereof |
| 12/16/2009 | CN101606062A Methods and compositions for treatment and diagnosis of autoimmune encephalitis or epilepsy |
| 12/16/2009 | CN101605893A Novel method of protecting islet cells from apoptosis during the donor harvesting process |
| 12/16/2009 | CN101605811A Treatment of cachexia |
| 12/16/2009 | CN101605810A Chimeric human sweet-umami and umami-sweet taste receptors |
| 12/16/2009 | CN101605809A Starch binding domain and use thereof |
| 12/16/2009 | CN101605808A Recombinant antigens of human cytomegalovirus (HCMV) |
| 12/16/2009 | CN101605807A Improved expression system for recombinant human arginase I |
| 12/16/2009 | CN101605558A Influenza recombinant subunit vaccine |
| 12/16/2009 | CN101603047A Establishment of prokaryotic expression and purification as well as test method of reconstruction human kidney injury molecule 1 (KIM-1) |
| 12/16/2009 | CN101603046A Establishment of prokaryotic expression and purification as well as test method of reconstruction influenza A H1N1 virus nonstructural protein NS1 |
| 12/16/2009 | CN101603034A CHO cell line expressing bovine beta interferon and application thereof |
| 12/16/2009 | CN101603033A CHO cell line expressing bovine beta interferon and application thereof |
| 12/16/2009 | CN101603032A CHO cell line expressing porcine beta interferon and application thereof |
| 12/16/2009 | CN101602804A Method for preparing composition rich in alpha 1-antitrypsin from supernatant of a composition A+I by improved K-N method |
| 12/16/2009 | CN101602803A Preparation method of recombination human thymosin beta 16 |
| 12/16/2009 | CN101602802A Process for desalting Thymosin alpha1 |
| 12/16/2009 | CN101602801A Polyethyleneglycol modificatory tecombined human granulocyte colony stimulating factor mutant |
| 12/16/2009 | CN101602800A Protein of adjusting plant tolerant to low-phosphorus stress and its coding gene and application thereof |
| 12/16/2009 | CN101602799A Quick preparation method for protogenic antibacterial polypeptide in cicer arietinum |
| 12/16/2009 | CN101602798A Preparation method of casein |
| 12/16/2009 | CN101602797A Hepatitis gene Ly6cl and application thereof |
| 12/16/2009 | CN101602796A Selenium-containing active polypeptide, preparing method and application thereof |
| 12/16/2009 | CN101601986A Preparation method of chitosan-silicon dioxide compound hollow microballoon and application thereof |
| 12/16/2009 | CN100569947C Resistance gene Pi37 against rice blast and application thereof |
| 12/16/2009 | CN100569944C Production of polyketides and other natural products |
| 12/16/2009 | CN100569939C Product of transegenic plant for expressing coat protein of human rotavirus and use thereof for preventing infant diarrhea |
| 12/16/2009 | CN100569799C Modified serum albumin with reduced affinity for nickel and copper |
| 12/16/2009 | CN100569798C GLP-1 derivative |
| 12/16/2009 | CN100569297C Gene transfer-mediated angiogenesis therapy |
| 12/16/2009 | CN100569286C Attenuated strains of vibrio cholerae with freeze-dry type and modified biological security for orally inoculability |
| 12/15/2009 | US7632984 Modulation of flowering time by the pft1 locus |
| 12/15/2009 | US7632983 Expression of monoclonal antibodies in duckweed |
| 12/15/2009 | US7632980 Modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems |
| 12/15/2009 | US7632935 DNA encoding a mast cell-derived membrane protein |
| 12/15/2009 | US7632933 Corticotropin releasing factor 2 receptor agonists |
| 12/15/2009 | US7632931 Endogeneous nucleic acid fragment associated with an autoimmune disease, labeling method and reagent |
| 12/15/2009 | US7632920 Soluble, stable form of HDM2, crystalline forms thereof and methods of use thereof |
| 12/15/2009 | US7632917 Complex comprising peptide substrate such as synaptosomal associated protein, syntaxin, isoforms, vesicle-associated membrane protein, and motif of soluble NSF (N-ethylmaleimide-sensitive fusion protein) attachment protein receptor, reporter domain comprising red fluorescent protein |
| 12/15/2009 | US7632823 Compositions of tRNA and uses thereof |
| 12/15/2009 | US7632816 Treatment of Alzheimer amyloid deposition |
| 12/15/2009 | US7632815 Treating or preventing myocardial contractile dysfunction that occurs after a myocardial infarction or other structural heart disease (e.g., end-stage valve disease) by by administering CaMK11 inhibitor, a peptide having a specific sequence of amino acids; dilated cardiomyopathy; transgenic animals |
| 12/15/2009 | US7632812 Methods to stimulate insulin production by pancreatic β-cells |
| 12/15/2009 | US7632811 A polypeptide produced by the parathyroid glands using such analogues alone or in combination with a bisphosphonate or calcitonin to treat osteoporosis |
| 12/15/2009 | US7632809 Multimeric ligands with enhanced stability |
| 12/15/2009 | US7632808 Use of MP52 or MP121 for the treatment and prevention of diseases of the nervous system |
| 12/15/2009 | US7632805 Administering a biodrug comprising a growth factor binding compounds having a central non-peptide organic scaffold, such as a calix[4]arene, to which arelinked cyclic tetrapeptides; angiogenesis inhibiters; antitumor agents; solid tumors;anticarciogenic agents; restenosis |
| 12/15/2009 | US7632802 Reducing the risk of infection in a patient with lowered neutrophil count byadministering an immunostimulant S100 protein; immunosuppressed, chemotherapy-treatedpatients and those having bone marrow transplant; measurement of neutrophil bloodconcentrations; side effect reduction; cost efficiency |
| 12/15/2009 | US7632801 Identification and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication |
| 12/15/2009 | US7632677 Cell line expressing mutated human tissue-type plasminogen activator, the constructing strategy thereof and method of preparing expressed protein |
| 12/15/2009 | US7632667 Mutan endonuclease with substrate-specific cleavage activity |
| 12/15/2009 | US7632660 protein is encoded by nucleic acid molecules that interact or bind to B-aggressive lymphoma (BAL) molecules, which are differentially expressed in non-Hodgkin's lymphoma; diagnostic use; biodrug for treating B-cell lymphoma |
| 12/15/2009 | US7632647 Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes |
| 12/15/2009 | US7632646 Tuberculosis diagnostic test |
| 12/15/2009 | US7632643 PCA3, PCA3 genes, and methods of use |
| 12/15/2009 | US7632640 Association of TSPYL polymorphisms with SIDDT syndrome |
| 12/15/2009 | US7632516 Moraxella catarrhalis BASB115 polypeptides |
| 12/15/2009 | US7632515 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 12/15/2009 | US7632514 a universal polypeptidic carrier for targeting molecules to a Gb3 receptor for the B-subunit of Shiga-Toxin expressing cells and its use for intracellular transport and processing of proteins, peptides, oligopeptides, glycoproteins, etc |
| 12/15/2009 | US7632513 amino acid sequence of subunit A of a cholera toxin (CT-A) or a fragment of the amino acid sequence of subunit A of an Escherichia coli heat labile toxin (LT-A) or a fragment, where in Ser-63 and Arg-192 are replaced with another amino acid |
| 12/15/2009 | US7632512 Use of polynucleotides encoding small acid-soluble spore protein for inhibiting bacterial cell growth and/or treating bacterial infections |
| 12/15/2009 | US7632510 Methods of inducing flavivirus immune responses through the administration of recombinant flaviviruses comprising an engineered japanese encephalitis virus signal sequence |
| 12/15/2009 | US7632507 Comprises nucleotide sequences coding synoviolin polypeptide for identifying modulators for treatment of arthritic and inflammatory disorders |
| 12/15/2009 | US7632504 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability |
| 12/15/2009 | US7632503 Using human insulin-like growth factor-1 (IGF-1) fusion protein as therapeutic in treatment and prevention of muscular disorders |
| 12/15/2009 | US7632502 Immunoglobulin for diagnosis and prevention of yeast infections |
| 12/15/2009 | US7632500 Immunoglobulin for use in prevention and treatment inflammatory disease |
| 12/15/2009 | CA2456037C Paget disease of bone |
| 12/15/2009 | CA2421907C A screening method for a substance having hypoglycemic activity by using stat-induced inhibitor of stat function-1 |
| 12/15/2009 | CA2411968C Protein glycosylation modification in pichia pastoris |
| 12/15/2009 | CA2361635C Methods and compositions for healing and repair of articular cartilage |
| 12/15/2009 | CA2358787C Oil maintenance indicator |
| 12/15/2009 | CA2345138C Polymer conjugates of interferon beta-1a and their uses |
| 12/15/2009 | CA2344049C Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway |
| 12/15/2009 | CA2337965C Attenuated equine herpesvirus |
| 12/15/2009 | CA2294996C Angiotensin derivatives |
| 12/15/2009 | CA2248960C Stable factor viii/vwf-complex |
| 12/15/2009 | CA2243088C Humanized green fluorescent protein genes and methods |
| 12/15/2009 | CA2226833C Adenovirus vectors for gene therapy |
| 12/10/2009 | WO2009149443A2 A metal-citrate transporter antigen from streptomyces coelicolor and uses thereof |
| 12/10/2009 | WO2009149393A2 Improved cancer drug delivery using modified transferrin |
| 12/10/2009 | WO2009149339A2 P53 activator peptides |
| 12/10/2009 | WO2009149281A1 Immunotoxins and uses thereof |
| 12/10/2009 | WO2009149278A1 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| 12/10/2009 | WO2009149205A2 Cell lines that secrete soluble vegf receptors and uses thereof |
| 12/10/2009 | WO2009149171A2 Fgf21 mutants and uses thereof |
| 12/10/2009 | WO2009149148A2 Long-acting glp-1 derivatives, and methods of treating cardiac dysfunction |
| 12/10/2009 | WO2009149021A2 Xbp1, cd138, and cs1 peptides |